GHGuohua Hu

Guohua Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guohua Hu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Jiayun Wang

    Department of Gynecology of Traditional Chinese Medicine, Shanghai Traditional Chinese Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    3 shared publications
  • Jiami Huang

    Department of Gynecology of Traditional Chinese Medicine, Shanghai Traditional Chinese Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    2 shared publications
  • Jing Chen

    Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    2 shared publications
  • Xu Zhang

    Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    2 shared publications
  • Yanan Zhang

    Department of Gynecology of Traditional Chinese Medicine, Shanghai Traditional Chinese Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    2 shared publications
  • Bo Sun

    Fangta T.C.M Hospital of Songjiang District Shanghai, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Mechanism of quercetin in the treatment of endometriosis based on network pharmacology and transcriptome sequencing

    by Jiami Huang, Jie Ding, Jiayun Wang, Yanan Zhang, Bo Sun, Guohua Hu, Jing Chen

    This study explores how quercetin may treat endometriosis (EMs) by combining network pharmacology and transcriptome sequencing approaches. Through network pharmacology, 132 shared targets between quercetin and EMs were identified, with KEGG pathway analysis suggesting that the MAPK signaling pathway could be a significant therapeutic target. Transcriptome sequencing revealed that PDGFRB was highly expressed in ectopic endometrial tissue, a finding confirmed by immunohistochemistry (IHC) showing elevated levels of PDGFRB, RAS, RAF1, and ERK1/2 in ectopic lesions. In an EMs mouse model, quercetin treatment led to a marked reduction in ectopic lesion volume, lowered adhesion scores, and decreased expression of PDGFRB, RAS, RAF1, and ERK1/2 in endometrial tissues. Additionally, the knockdown of PDGFRB in endometriosis cells inhibited their proliferation, invasion, and migration, processes critical to EMs pathology. Quercetin treatment further suppressed cell viability and downregulated the protein expression of RAS, phosphorylated RAF1, RAF1, phosphorylated ERK, and ERK1/2. These findings collectively suggest that quercetin exerts its therapeutic effect in endometriosis by regulating the MAPK signaling pathway via PDGFRB, thereby reducing EMs cell proliferation, invasion, and migration. This study provides insights into quercetin’s multi-targeted mechanism of action in endometriosis treatment.


  • Open Access

    Mechanism of Yushenhuoxue prescription in treating endometriosis based on network pharmacology and the effect on the TNF pathway

    by Jiami Huang, Xu Zhang, Jiayun Wang, Cancan Gu, Yanan Zhang, Guohua Hu, Jing Chen


  • Open Access

    Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR‐6838‐5p

    by Xu Zhang, Jiami Huang, Jiayun Wang, Yongheng Li, Guohua Hu, He Li

    Background: An increasing number of circular RNAs (circRNAs) have been shown to play an important role in the tumorigenesis of breast cancer. The aim of this study was to investigate the expression and function of circ_0001667 and its potential molecular mechanisms in breast cancer.Methods: The expression levels of circ_0001667, miR‐6838‐5p and CXC chemokine ligand 10 (CXCL10) in breast cancer tissues and cells were detected by quantitative real‐time PCR. Cell counting kit‐8 assay, EdU assay, flow cytometry, colony formation and tube formation assays were used to detect cell proliferation and angiogenesis. The binding relationship between miR‐6838‐5p and circ_0001667 or CXCL10 was predicted using the starBase3.0 database and verified by dual‐luciferase reporter gene assay, RIP and RNA pulldown. Animal experiments were performed to assess the function of circ_0001667 knockdown on breast cancer tumor growth.Results: Circ_0001667 was highly expressed in breast cancer tissues and cells, and its knockdown inhibited proliferation and angiogenesis of breast cancer cells. Circ_0001667 sponged miR‐6838‐5p, and inhibition of miR‐6838‐5p reversed the inhibitory effect of silencing circ_0001667 on proliferation and angiogenesis of breast cancer cells. MiR‐6838‐5p targeted CXCL10, and overexpression of CXCL10 reverses the effect of miR‐6838‐5p overexpression on breast cancer cell proliferation and angiogenesis. In addition, circ_0001667 interference also reduced breast cancer tumor growth in vivo.Conclusion: Circ_0001667 is involved in breast cancer cell proliferation and angiogenesis through regulation of the miR‐6838‐5p/CXCL10 axis.